Prognostic significance of obstructive uropathy in advanced prostate cancer

Urology

Volumn 63, Issue 6, 2004, Pages 1117-1121

  Oefelein, Michael G ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN;

ADVANCED CANCER; AGED; ARTICLE; BALLOON CATHETER; BLADDER OBSTRUCTION; CANCER CYTODIAGNOSIS; CANCER GRADING; CANCER INCIDENCE; CANCER SURVIVAL; CHI SQUARE DISTRIBUTION; CONTROLLED STUDY; DISEASE ASSOCIATION; HORMONE RESISTANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSTRUCTIVE UROPATHY; PERCUTANEOUS NEPHROSTOMY; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CARCINOMA; STATISTICAL ANALYSIS; SURVIVAL RATE; TRANSURETHRAL RESECTION; URETER OBSTRUCTION; URETER STENT; URINARY DIVERSION;

ADENOCARCINOMA; AGED; COMORBIDITY; DISEASE PROGRESSION; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; NEPHROSTOMY, PERCUTANEOUS; PROGNOSIS; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIOTHERAPY, ADJUVANT; STENTS; SURVIVAL RATE; UNITED STATES; URINARY BLADDER NECK OBSTRUCTION; URINARY CATHETERIZATION;

EID: 2942581562     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urology.2004.01.026     Document Type: Article

References (16)

1. Chiou R.K., Chang W.Y., Horan J.J. Ureteral obstruction associated with prostate cancer the outcome after percutaneous nephrostomy. J Urol. 143:1990;957-969
2. Dowling R.A., Carrasco C.H., Babaian R.J. Percutaneous urinary diversion in patients with hormone-refractory prostate cancer. Urology. 37:1991;89-91
3. de Lichtenberg H.M., Miskowiak J., Rolff H. Hormonal treatment of obstructed kidneys in patients with prostatic cancer. Br J Urol. 71:1993;313-316
4. Paul A.B., Love C., Chisholm G.D. The management of bilateral ureteric obstruction and renal failure in advanced prostate cancer. Br J Urol. 74:1994;642-645
5. Colombel M., Mallame W., Abbou C.C. Influence of urological complications on the prognosis of prostate cancer. Eur Urol. 31:(suppl 3):1997;21-24
6. Fowler J.E. Jr, Bigler S.A., White P.C., et al. Hormone therapy for locally advanced prostate cancer. J Urol. 168:2002;546-549
7. Sandhu D.P., Mayor P.E., Sambrook P.A., et al. Outcomes and prognostic factors in patients with advanced prostate cancer and obstructive uropathy. Br J Urol. 70:1992;412-416
8. Schellhamer P.F., Whitmore R.B., Kuban D.A., et al. Morbidity and mortality of local failure after definitive therapy for prostate cancer. J Urol. 141:1989;567-571
9. Michigan S., Catalona W.J. Ureteral obstruction from prostatic carcinoma response to endocrine and radiation therapy. J Urol. 118:1977;733-738
10. Albertsen P.C., Hanley J.A., Murphy-Setzko M. Statistical considerations when assessing outcomes following treatment for prostate cancer. J Urol. 162:1999;439-444
11. Levine E.S., Cisek V.J., Mulvihill M.N., et al. Role of transurethral resection in dissemination of cancer of the prostate. Urology. 28:1986;179-183
12. Nativ O., Bergstralh E.J., Boyle E.T., et al. Transurethral resection versus needle biopsy prior to radical prostatectomy for stage C prostate cancer influence on progression and survival. Urology. 37:1991;22-27
13. Gibbons R.P., Mason J.T., Correa R.J., et al. Carcinoma of the prostate local control with external beam radiation therapy. J Urol. 121:1979;310-312
14. Holman M., Carlton C.E., Scardino P.T. The frequency and morbidity of local tumor recurrence after definitive radiotherapy for stage C prostate cancer. J Urol. 146:1991;1578-1582
15. Rosen E., Cassady J.R., Connolly J., et al. Radiotherapy for prostate carcinoma the JCRT experience (1968-1978). II. Factors related to tumor control and complications. Int J Radiat Oncol Biol Phys. 11:1985;723-730
16. Roach M. III, Desilvio M., Lawton C., et al. Phase III trial comparing whole pelvis versus prostate only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression Radiation Therapy Oncology Group 9413. J Clin Oncol. 21:2003;1904-1911